» Articles » PMID: 2197371

Analysis of the Local and Systemic Immune Responses Induced in BALB/c Mice by Experimental Respiratory Syncytial Virus Infection

Overview
Journal J Gen Virol
Specialty Microbiology
Date 1990 Jul 1
PMID 2197371
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary A2 strain respiratory syncytial virus infection of BALB/c laboratory mice persisted for up to 7 days after initial infection with peak virus titres being recovered on day 4. Virus antigen within the lungs was found to be restricted essentially to the alveolar regions. Similarly, pulmonary histopathological changes remained confined to the peri-alveolar regions being consistent with mild pneumonia. Infection was found to elicit a pulmonary major histocompatibility complex-restricted cytotoxic T lymphocyte (CTL) response which was first detectable 6 days after infection and optimal 7 to 9 days after infection. This local CTL response was preceded by a rapid transient virus-specific lymphocyte transformation response which was detectable only 3 days after intranasal infection. In addition, infection induced rapid interferon production within the lungs which was accompanied by an equally rapid rise in pulmonary natural killer (NK) cell cytotoxic activity. Enhanced NK cell cytotoxicity could be detected after only 1 day post-infection and continued to rise to maximum levels on day 3. This response like the acute CTL response was found to be restricted to the lower respiratory tract. IgG was the first class of virus-specific immunoglobulin to be detected in the lungs of infected animals after experimental infection. However, IgG was not detected until day 10 post-infection, 5 days after the initial decline of virus shedding. Virus-specific IgA although detectable did not appear in the lung until day 24.

Citing Articles

Immunity Cell Responses to RSV and the Role of Antiviral Inhibitors: A Systematic Review.

Churiso G, Husen G, Bulbula D, Abebe L Infect Drug Resist. 2022; 15:7413-7430.

PMID: 36540102 PMC: 9759992. DOI: 10.2147/IDR.S387479.


Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.

Ye X, Iwuchukwu O, Avadhanula V, Aideyan L, McBride T, Ferlic-Stark L Front Immunol. 2019; 10:706.

PMID: 30984206 PMC: 6449644. DOI: 10.3389/fimmu.2019.00706.


T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Monette A, Mouland A Int Rev Cell Mol Biol. 2019; 342:175-263.

PMID: 30635091 PMC: 7104940. DOI: 10.1016/bs.ircmb.2018.07.006.


Small Animal Models of Respiratory Viral Infection Related to Asthma.

Han M, Rajput C, Ishikawa T, Jarman C, Lee J, Hershenson M Viruses. 2018; 10(12).

PMID: 30513770 PMC: 6316391. DOI: 10.3390/v10120682.


Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Griffiths C, Drews S, Marchant D Clin Microbiol Rev. 2016; 30(1):277-319.

PMID: 27903593 PMC: 5217795. DOI: 10.1128/CMR.00010-16.